Rod Kunynetz

855 total citations
11 papers, 661 citations indexed

About

Rod Kunynetz is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Rod Kunynetz has authored 11 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Dermatology, 5 papers in Immunology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Rod Kunynetz's work include Acne and Rosacea Treatments and Effects (5 papers), Dermatology and Skin Diseases (5 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Rod Kunynetz is often cited by papers focused on Acne and Rosacea Treatments and Effects (5 papers), Dermatology and Skin Diseases (5 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Rod Kunynetz collaborates with scholars based in Canada, Puerto Rico and France. Rod Kunynetz's co-authors include Alan Menter, Scott Fretzin, Arthur Kavanaugh, Yaung‐Kaung Shen, Cynthia Guzzo, Alan M. Mendelsohn, Shu Li, Alice B. Gottlieb, Charles Lynde and Yves Poulin and has published in prestigious journals such as The Lancet, British Journal of Dermatology and Journal of Cutaneous Medicine and Surgery.

In The Last Decade

Rod Kunynetz

11 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rod Kunynetz Canada 9 434 255 249 176 69 11 661
Chandrasena Pamulapati United States 6 570 1.3× 218 0.9× 294 1.2× 196 1.1× 66 1.0× 8 717
Arianna Zangrilli Italy 13 432 1.0× 277 1.1× 145 0.6× 94 0.5× 75 1.1× 38 547
Scott Fretzin United States 10 820 1.9× 474 1.9× 303 1.2× 206 1.2× 128 1.9× 14 1.0k
A. Maza France 11 297 0.7× 212 0.8× 129 0.5× 38 0.2× 158 2.3× 24 593
R.E. Schopf Germany 9 332 0.8× 144 0.6× 107 0.4× 74 0.4× 46 0.7× 17 585
Melissa Magliocco United States 5 346 0.8× 166 0.7× 118 0.5× 73 0.4× 32 0.5× 9 466
M. Milutinovic Switzerland 7 965 2.2× 637 2.5× 197 0.8× 146 0.8× 217 3.1× 12 1.0k
P.P.M. van Lümig Netherlands 15 497 1.1× 297 1.2× 123 0.5× 52 0.3× 66 1.0× 18 605
Leire González‐Lara Spain 13 328 0.8× 152 0.6× 106 0.4× 38 0.2× 43 0.6× 22 433
Wendell C. Valdecantos United States 17 503 1.2× 386 1.5× 101 0.4× 29 0.2× 75 1.1× 32 618

Countries citing papers authored by Rod Kunynetz

Since Specialization
Citations

This map shows the geographic impact of Rod Kunynetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rod Kunynetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rod Kunynetz more than expected).

Fields of papers citing papers by Rod Kunynetz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rod Kunynetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rod Kunynetz. The network helps show where Rod Kunynetz may publish in the future.

Co-authorship network of co-authors of Rod Kunynetz

This figure shows the co-authorship network connecting the top 25 collaborators of Rod Kunynetz. A scholar is included among the top collaborators of Rod Kunynetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rod Kunynetz. Rod Kunynetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Guenther, Lyn, Rod Kunynetz, Charles Lynde, et al.. (2017). Acitretin Use in Dermatology. Journal of Cutaneous Medicine and Surgery. 21(3_suppl). 2S–12S. 27 indexed citations
2.
Brodmerkel, Carrie, Eric Wadman, Richard G. Langley, et al.. (2013). Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use.. PubMed. 12(10). 1122–9. 51 indexed citations
3.
Thomas, Richard, Ian Landells, Charles Lynde, et al.. (2012). Canadian Consensus on Skin Barrier Repair Therapy in Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery. 16(1_suppl). S1–S15. 1 indexed citations
4.
5.
Poulin, Yves, Néstor P. Sánchez, A Bucko, et al.. (2011). A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial. British Journal of Dermatology. 164(6). 1376–1382. 51 indexed citations
6.
Gottlieb, Alice B., Alan Menter, Alan M. Mendelsohn, et al.. (2009). Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. The Lancet. 373(9664). 633–640. 446 indexed citations
7.
Kunynetz, Rod. (2004). A review of systemic retinoid therapy for acne and related conditions.. PubMed. 9(3). 1–4. 21 indexed citations
10.
Kunynetz, Rod. (2002). Systemic antibiotic therapy for acne: a review.. PubMed. 7(5). 3–7. 4 indexed citations
11.
Lipa, Michael, et al.. (1982). The occurrence of mycosis fungoides in two patients with preexisting Hodgkin's disease.. PubMed. 118(8). 563–7. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026